Effects of alpha calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery

Regulatory Peptides

Volumn 118, Issue 3, 2004, Pages 127-134

  Springer, Jochen ^a   Amadesi, Silvia ^b   Trevisani, Marcello ^c   Harrison, Selena ^c   Dinh, Q Thai ^a   McGregor, Gerald P ^d   Fischer, Axel ^a   Geppetti, Pierangelo ^e   Groneberg, David A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Airway tone; Airways; Immunohistochemistry; Neuropeptide; Respiratory tract; Vascular tone

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER;

ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; ASTHMA; BLOOD VESSEL TONE; BRONCHOSPASM; BRONCHUS MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCENTRATION RESPONSE; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE; NEUROEPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ACETYLCHOLINE; BRONCHI; CALCITONIN GENE-RELATED PEPTIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NERVE FIBERS; NG-NITROARGININE METHYL ESTER; PEPTIDE FRAGMENTS; PHENYLEPHRINE; PULMONARY ARTERY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

EID: 1542360661     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2003.11.006     Document Type: Article

References (50)

1. Tattersfield A.E., Knox A.J., Britton J.R., Hall I.P. Asthma. Lancet. 360:2002;1313-1322.
2. Barnes P.J., Chung K.F., Page C.P. Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50:1998;515-596.
3. Springer J., Geppetti P., Fischer A., Groneberg D.A. Calcitonin gene-related peptide as inflammatory mediator. Pulm. Pharmacol. Ther. 16:2003;121-130.
4. Kraneveld A.D., Nijkamp F.P. Tachykinins and neuro-immune interactions in asthma. Int. Immunopharmacol. 1:2001;1629-1650.
5. Groneberg D.A., Springer J., Fischer A. Vasoactive intestinal polypeptide as mediator of asthma. Pulm. Pharmacol. Ther. 14:2001;391-401.
6. Fischer A., Folkerts G., Geppetti P., Groneberg D.A. Mediators of asthma: nitric oxide. Pulm. Pharmacol. Ther. 15:2002;73-81.
7. Eynott P.R., Groneberg D.A., Caramori G., Adcock I.M., Donnelly L.E., Kharitonov S., et al. Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. Eur. J. Pharmacol. 452:2002;123-133.
8. Groneberg D.A., Fischer A. Endogenous opioids as mediators of asthma. Pulm. Pharmacol. Ther. 14:2001;383-389.
9. Olgart Hoglund C., Frossard N. Nerve growth factor and asthma. Pulm. Pharmacol. Ther. 15:2002;51-60.
10. Juaneda C., Dumont Y., Quirion R. The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol. Sci. 21:2000;432-438.
11. Hoppener J.W., Steenbergh P.H., Zandberg J., Geurts van Kessel A.H., Baylin S.B., Nelkin B.D., et al. The second human calcitonin/CGRP gene is located on chromosome 11. Hum. Genet. 70:1985;259-263.
12. Kennedy S.P., Sun D., Oleynek J.J., Hoth C.F., Kong J., Hill R.J. Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem. Biophys. Res. Commun. 244:1998;832-837.
13. Hanze J., Groneberg D.A., Rose F., Hanisch A., Dotsch J., Peiser C., et al. Genomic organization and regulation of a human 7-helix transmembrane receptor which is expressed in pulmonary epithelial cells and induced in hypoxia. Biochem. Biophys. Res. Commun. 291:2002;1160-1165.
14. Groneberg D.A., Hartmann P., Dinh Q.T., Fischer A. Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airways. Lab. Invest. 81:2001;749-755.
15. Fischer T.C., Hartmann P., Loser C., Springer J., Peiser C., Dinh Q.T., et al. Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skin. J. Invest. Dermatol. 117:2001;754-756.
16. Groneberg D.A., Welker P., Fischer T.C., Dinh Q.T., Grutzkau A., Peiser C., et al. Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J. Allergy Clin. Immunol. 111:2003;1099-1105.
17. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., et al. International union of pharmacology: XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 54:2002;233-246.
18. Fitzsimmons T.J., Zhao X., Wank S.A. The extracellular domain of receptor activity-modifying protein 1 (RAMP 1) is sufficient for calcitonin receptor-like receptor (CRLR) function. J. Biol. Chem. 278:2003;14313-14320.
19. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
20. Hagner S., Haberberger R., Kummer W., Springer J., Fischer A., Bohm S., et al. Immunohistochemical detection of calcitonin gene-related peptide receptor (CGRPR)-1 in the endothelium of human coronary artery and bronchial blood vessels. Neuropeptides. 35:2001;58-64.
21. Palmer J.B., Cuss F.M., Mulderry P.K., Ghatei M.A., Springall D.R., Cadieux A, et al. Calcitonin gene-related peptide is localised to human airway nerves and potently constricts human airway smooth muscle. Br. J. Pharmacol. 91:1987;95-101.
22. Keith I.M., Tjen A.L.S., Kraiczi H., Ekman R. Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H1571-H1578.
23. Qing X., Svaren J., Keith I.M. mRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:2001;L547-L554.
24. Heppt W., Peiser C., Cryer A., Dinh Q.T., Zweng M., Witt C, et al. Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis. J. Occup. Environ. Med. 44:2002;924-929.
25. Dakhama A., Kanehiro A., Makela M.J., Loader J.E., Larsen G.L., Gelfand E.W. Regulation of airway hyperresponsiveness by calcitonin gene-related peptide in allergen sensitized and challenged mice. Am. J. Respir. Crit. Care Med. 165:2002;1137-1144.
26. Groneberg D.A., Heppt W., Cryer A., Wussow A., Peiser C., Zweng M, et al. Toxic rhinitis-induced changes of human nasal mucosa innervation. Toxicol. Pathol. 31:2003;326-331.
27. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8400-8405.
28. Trevisani M., Smart D., Gunthorpe M.J., Tognetto M., Barbieri M., Campi B, et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat. Neurosci. 5:2002;546-551.
29. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., Ennes HS, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6:2000;151-158.
30. Groneberg D.A., Eynott P.R., Doring F., Thai Dinh Q., Oates T., Barnes PJ, et al. Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung. Thorax. 57:2002;55-60.
31. Tognetto M., D'Andrea M.R., Trevisani M., Guerrini R., Salvadori S., Spisani L, et al. Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro. Br. J. Pharmacol. 139:2003;21-27.
32. Amadesi S., Moreau J., Tognetto M., Springer J., Trevisani M., Naline E, et al. NK1 receptor stimulation causes contraction and inositol phosphate increase in medium-size human isolated bronchi. Am. J. Respir. Crit. Care Med. 163:2001;1206-1211.
33. Fischer T.C., Dinh Q.T., Peiser C., Loser C., Fischer A., Groneberg D.A. Simultaneous detection of receptor mRNA and ligand protein in human skin tissues. J. Cutan. Pathol. 29:2002;65-71.
34. Groneberg D.A., Nickolaus M., Springer J., Doring F., Daniel H., Fischer A. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am. J. Pathol. 158:2001;707-714.
35. DeWitt B.J., Cheng D.Y., Caminiti G.N., Nossaman B.D., Coy D.H., Murphy WA, et al. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the pulmonary vascular bed of the cat. Eur. J. Pharmacol. 257:1994;303-306.
36. Matran R., Alving K., Martling C.R., Lacroix J.S., Lundberg J.M. Vagally mediated vasodilatation by motor and sensory nerves in the tracheal and bronchial circulation of the pig. Acta Physiol. Scand. 135:1989;29-37.
37. Matran R., Alving K., Martling C.R., Lacroix J.S., Lundberg J.M. Effects of neuropeptides and capsaicin on tracheobronchial blood flow of the pig. Acta Physiol. Scand. 135:1989;335-342.
38. Martling C.R., Matran R., Alving K., Lacroix J.S., Lundberg J.M. Vagal vasodilatory mechanisms in the pig bronchial circulation preferentially involves sensory nerves. Neurosci. Lett. 96:1989;306-311.
39. McCormack D.G., Mak J.C., Coupe M.O., Barnes P.J. Calcitonin gene-related peptide vasodilation of human pulmonary vessels. J. Appl. Physiol. 67:1989;1265-1270.
40. Chauhan M., Thota C.S., Kondapaka S., Wimalawansa S., Yallampalli C. Evidence for the existence of a new receptor for CGRP, which is not CRLR. Peptides. 24:2003;65-71.
41. Salonen R.O., Webber S.E., Widdicombe J.G. Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo. Br. J. Pharmacol. 95:1988;1262-1270.
42. Parsons G.H., Nichol G.M., Barnes P.J., Chung K.F. Peptide mediator effects on bronchial blood velocity and lung resistance in conscious sheep. J. Appl. Physiol. 72:1992;1118-1122.
43. de Hoon J.N., Pickkers P., Smits P., Struijker-Boudier H.A., Van Bortel L.M. Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans. Clin. Pharmacol. Ther. 73:2003;312-321.
44. Keith I.M. The role of endogenous lung neuropeptides in regulation of the pulmonary circulation. Physiol. Res. 49:2000;519-537.
45. Roncalli M., Springall D.R., Maggioni M., Moradoghli-Haftvani A., Winter R.J., Zhao L, et al. Early changes in the calcitonin gene-related peptide (CGRP) content of pulmonary endocrine cells concomitant with vascular remodeling in the hypoxic rat. Am. J. Respir. Cell Mol. Biol. 9:1993;467-474.
46. Mannan M.M., Springall D.R., Enard C., Moradoghli-Haftvani A., Eddahibi S., Adnot S, et al. Decreased endothelium-dependent pulmonary vasodilator effect of calcitonin gene-related peptide in hypoxic rats contrasts with increased binding sites. Eur. Respir. J. 8:1995;2029-2037.
47. Tjen A.L.S., Kraiczi H., Ekman R., Keith I.M. Sensory CGRP depletion by capsaicin exacerbates hypoxia-induced pulmonary hypertension in rats. Regul. Pept. 74:1998;1-10.
48. Qing X., Wimalawansa S.J., Keith I.M. Specific N-terminal CGRP fragments mitigate chronic hypoxic pulmonary hypertension in rats. Regul. Pept. 110:2003;93-99.
49. Rogers D.F., Belvisi M.G., Aursudkij B., Evans T.W., Barnes P.J. Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs. Br. J. Pharmacol. 95:1988;1109-1116.
50. Cadieux A., Monast N.P., Pomerleau F., Fournier A., Lanoue C. Bronchoprotector properties of calcitonin gene-related peptide in guinea pig and human airways. Effect of pulmonary inflammation. Am. J. Respir. Crit. Care Med. 159:1999;235-243.